Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden

European Journal of Cancer

Volumn 42, Issue 16, 2006, Pages 2773-2780

  Christensen, L H ^a,b   Engholm, G ^b   Cortes, R ^b   Ceberg, J ^c   Tange, U ^d   Andersson, M ^d   Bladstrom A ^c   Mouridsen, H T ^d,e   Moller T ^c   Storm, Hans ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d Rigshospitalet   (Denmark)

^e Danish Breast Cancer Cooperative Group   (Denmark)

Author keywords

Breast cancer survival; Mammography; Patient delay; Screening

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; DENMARK; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DENMARK; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MORTALITY; SURVIVAL ANALYSIS; SWEDEN;

EID: 33750036128     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.03.036     Document Type: Article

References (33)

1. Reintgen D., Cox C., Greenberg H., et al. The medical legal implications of following mammographic breast masses. Ann Surg 59 (1993) 99-105
2. Burgess C.C., Ramirez A.J., Richards M.A., and Love S.B. Who and what influences delayed presentation in breast cancer?. Br J Cancer 77 (1998) 1343-1348
3. Raabe N.K., and Fossaa S.D. Primary invasive breast carcinoma in Oslo 1980-1989, incidence and delay. Acta Oncol 35 (1996) 9-15
4. Olivotto I.A., Gomi A., Bancej C., et al. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 94 (2002) 2143-2150
5. Neave L., Mason B., and Kay R. Does delay in diagnosis of breast cancer affect survival?. Breast Cancer Res Treat 15 (1990) 103-108
6. Afzelius P., Zedeler K., Sommer H., Mouridsen H.T., and Blichert-Toft M. Patient's and doctor's delay in primary breast cancer. Acta Oncol 33 (1994) 345-351
7. Wilkinson G.S., Edgerton F., James Wallace H., Reese Jr. P., Patterson J., and Priore R. Delay, stage of disease and survival from breast cancer. J Chron Dis 32 (1979) 365-373
8. Ramirez A.J., Westcombe A.M., Burgess C.C., Sutton S., Littlejohns P., and Richards M.A. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 353 (1999) 1127-1131
9. Richards M.A., Smith P., Ramirez A.J., Fentiman I.S., and Rubens R.D. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br. J Cancer 79 (1999) 858-864
10. Spratt J.A., von Founier D., Spratt J.S., and Weber E.E. Mammographic assessment of human breast cancer growth and duration. Cancer 71 (1993) 2020-2026
11. Spratt J.S., and Spratt S.W. Medical and legal implications of screening and follow-up procedures for breast cancer. Cancer 66 (1990) 1351-1362
12. Plotkin D., and Blankenberg F. Breast cancer: biology and malpractice. Am J Clin Oncol 14 (1991) 256-266
13. Fisher B., Redmond C., and Fisher E. The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology: an overview of findings. Cancer 46 (1980) 1009-1025
14. Parver C.P. Defense of delayed diagnosis and treatment of breast cancer. Med Trial Tech Quart 30 (1983) 34-63
15. Eggers C., deCholnoky T., and Jessup D.S. Cancer of the breast. Ann Surg 113 (1941) 321-340
16. Haagensen C.D., and Stout A.P. Carcinoma of the breast. 1. Results of treatment. Ann Surg 116 (1942) 801-815
17. McWhirter R. Some factors influencing prognosis in breast cancer. J Fac Radiol 8 (1957) 220-234
18. Bloom H.J.G. Further studies on prognosis of breast carcinoma. Br J Cancer 4 (1950) 347-367
19. Fisher E.R., Redmond C., and Fisher B. A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer 40 (1977) 3160-3167
20. Feldman J.G., Saunders M., Carter A.C., and Gardner B. The effects of patient delay and symptoms other than a lump on survival in breast cancer. Cancer 51 (1983) 1226-1229
21. Richards M.A., Westcombe A.M., Love S.B., Littlejohns P., and Ramirez A.J. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353 (1999) 1119-1126
22. Gabe R., and Duffy S.W. Evaluation of service screening mammography in practise: the impact on breast cancer mortality. Ann Oncol 16 suppl 2iil (2005) 53-62
23. Joensuu H., Lehtimäki T., Holli K., et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 292 (2004) 1064-1073
24. Shen Y., Yang Y., Inoue L.Y.T., Munsell M.F., and Miller A.B. Role of detection method in predicting breast cancer survival: analysis of randomized sceening trials. J Natl Cancer Inst 97 (2005) 1195-1203
25. The Swedish Organized Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15:45-51.
26. The Swedish Organized Service Screening Evaluation Group. Reduction in breast cancer mortality from the organized service screening with mammography: 2. Validation with alternative analysis methods. Cancer Epidemiol Biomarkers Prev 2006;15:52-56.
27. Engeland A., Haldorsen T., Dickman P.W., et al. Relative survival of cancer patients. A comparison between Denmark and the other Nordic countries. Acta Oncologica 37 (1998) 49-59
28. Christensen L.H., Engholm G., Ceberg J., et al. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomic variables? - a population-based study. Eur J Cancer 40 (2004) 1233-1243
29. Nyström L., Rutquist L., and Wall S. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341 (1993) 973-978
30. Lynge E., and and the Mammography Screening Group H:S Copenhagen hospital corporation. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. APMIS 106 suppl 83 (1998)
31. Tabar l., Duffy S.W., Vitak B., Chen H.-H., and Prevost T.C. The natural history of breast carcinoma. What have we learned from screening?. Cancer 86 (1999) 449-462
32. Jonsson H., Johansson R., and Lenner P. Increased incidence of invasive breast cancer after introduction of service screening with mammography in Sweden. Int J Cancer 117 (2005) 842-847
33. Louwman W.J., Janssen-Heijnen M.L.G., Houterman S., et al. Less extensive treatment and inferior prognosis for breast cancer patients with comorbidity: a population-based study. Eur J Cancer 41 (2005) 779-785